The size of the global flow cytometry market is forecasted to grow USD 4270 Million in 2020 and to reach USD 7030 Million by 2025. This market is growing at a CAGR of 10.5% during the forecast period from 2020 to 2025.
Flow cytometry is a laser-based biophysical methodical technology that procedures and examines several physical features of particles postponed in a fluid as they pass through a laser beam. Flow cytometry has several advantages over traditional analytical methods, such as ELISA, which includes its ability to provide accurate and precise results, and less time-consuming at approximately the same prices.
Flow cytometry technology uses in several areas of academic research and diagnosis of diseases such as HIV, hematologic malignancies, and cancer. The growing number of patients with cancer and HIV and the increasing use of flow cytometry in hospitals and diagnostic centers have created an imminent need for flow cytometry for effective diagnosis and surveillance of the disease. The fluorescence stimulated cell sorting or FACS used in flow cytometry has ensured a healthy future in the market.
COVID-19 Impact on the Flow Cytometry Market
The continuous COVID-19 pandemic and the reaction across the globe has caused industries to seriously re-think their strategies and the way to operate. Biopharmaceutical creators are at the forefront of human responsibility towards the coronavirus pandemic.
MARKET DRIVERS
The increasing occurrence rate of chronic and infectious diseases like cancer and HIV are boosting the market growth of Flow Cytometry. Technological advancements, growing acquisition in cytometry techniques, increasing market perforation in existing countries, and growth in stem cell research and acquisition of recombination of DNA technologies for antibody protection are further likely to augment the growth rate of the market.
Flow cytometry is an impedance or laser technology used in biomarker detection, cell counting, and protein engineering. It allows a detailed study of cellular structures using the software.
MARKET RESTRAINTS
The retraining factors that are challenging the growth of the flow cytometry market are the availability of alternate and cheaper techniques, high costs associated with flow cytometry reagents and instruments, budget restrictions for research purposes, expensive installation, and maintenance costs.
High costs associated and the scarcity of labor and skilled technicians in the lab and clinics also hampering the flow cytometry market growth to some extent. Additionally, the lack of awareness among the end-users and less accessibility of technical expertise is further restraining the market growth during the analysis period.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Technology, Product, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
This market research report on the Global Flow Cytometry Market has been segmented and sub-segmented based on technology, product, application, end-user, and region.
Flow Cytometry Market - By Technology
Based on technology, the bead-based technology segment is dominating the market. It is to increase during the forecast period owing to market boosting like high speed and stability, high reproducibility, its ability to detect multiple analytes.
The bead-based segment is considered to have fast growth in the flow cytometry market over the analysis period, and the segment growth owes to procedural advantages over the cell-based techniques.
Flow Cytometry Market - By Product
Based on the product, the reagents & consumables segment accounts for the largest share of the market in the global 2019. The segment growth owes to extensive usage of diagnostic applications, research on cell biology and immunology, commercialization, and development of reagents and assays with better quality are expected to fuel the flow cytometry market growth over the period.
The instruments segment is predicted to have the quickest growth of the market over the period due to the launch of novel technologies, correct results, and user-friendliness.
Flow Cytometry Market - By Application
Based on the application analysis, the research segment is expected to account for the largest share in terms of revenue. The segment's growth is driven by the research and development activities related to cancer and other infectious diseases, and this segment is mainly used for the pharmaceutical research segment. Various applications used across different industries fuel this application.
Flow Cytometry Market - By End-users
Based on the end-user analysis, the commercial organization's segment is considered to have the largest share of the flow cytometry market due to a wide range of applications such as food microbiology, blood banks, and plant cell culture.
Clinical testing labs are considered to have fast growth in flow cytometry over the period, and the increase is due to an increasing number of chronic diseases. A rise in organ transplantation practices helps market growth over the forecast period.
Flow Cytometry Market - By Region
Regionally, North America is the biggest market in terms of market share across the globe, followed by Europe. Factors driving the flow cytometry market in North America are increasing the application of flow cytometry techniques in cancer research, increasing adoption of low cost and compact flow cytometers in clinical diagnostics and research laboratories, and the rising quality of infrastructure for laboratory and clinical research. The U.S. is estimated to account for the leading shares in the North American market due to a massive number of clinical labs for researches and major pharmaceuticals and also a high occurrence of cancer rates and other chronic conditions. The Canadian market is expected to have the quickest growth rate followed by the U.S. in the North American flow cytometry market.
Europe is expected to perform well during the forecast period and is the second leading region, followed by North America in 2019. Factors like stem cell research, the existence of new and advanced technologies in the field of cytometry, surge in the application during clinical researches are strongly surging the market demand in Europe. The UK is expected to lead the European flow cytometry market during the forecast period.
The Flow Cytometry market in the Asia-Pacific region to grow at the highest CAGR, which is greatly due to increasing development and production of new biologics, vaccines, and drugs, expanding medical treatment for infectious and chronic diseases, rising median age of the population and increasing focus on attracting international and domestic players in the market.
Flow Cytometry in the Latin America region is expected to showcase a steady growth rate during the forecast period. The market growth in this region is attributed due to factors such as the growing rise of HIV and cancer cases, and increase use of flow cytometry for drug discovery is expected to fuel the market of this region. Mexico is the leading country in the region due to the high occurrence of cancer growth.
TOP COMPANIES IN THE MARKET
Key market participants leading the Global Flow Cytometry Market profiled in this report are Becton, Dickinson and Company., Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Agilent Technologies, Inc. and Affymetix Inc.
RECENT MARKET DEVELOPMENTS
On January 30, 2020, Miltenyi Biotech has introduced the world’s first operator with its new MACS GMP Tyto cartridge which creates opportunities for fluorescence-based, GMP-cell sorting compliant. It is used first on human trials, particularly in people with Parkinson’s disease.
On March 11, 2020, Sony has introduced its new fluorescent dyes KIRAVIA Dyes which is utilized for reagents for a wide range of life science applications. These are used for tissue and cells in this field, like immunology and regenerative medicine. These KIRAVIA Dyes are organic polymers which have fluorescent dyes loaded on novel organic polymer developed by Sony.
On June 04, 2019, Beckman Coulter Life Sciences had announced that it had acquired Cytobank. This Cytobank offers a software-based platform for multi-parametric single-cell data analysis, and this technology couple with Beckman’s CytoFLEX LX-21-color flow in meeting high complex workflow and requirement of clinical researchers.
On January 02, 2019, Luminex Corporation announced the acquisition with Millipore Sigma’s flow cytometry. This acquisition allows for increasing the flow-based detection systems as well as widening interactions based on microcapillary technologies.
In 2018, Becton Company launched a new product called BD FACSymphony S6 high parameter cell sorter.
IN 2018, ACEA biosciences and Agilent technologies entered into a partnership to expand their product portfolio and increase revenues.
In September 2017, Beckman Coulter, Inc. (United States) released its first CytoFLEX LX flow cytometry for cancer researchers, which has the visible spectrum in a standard configuration. This launch allowed us to develop its activity in flow cytometry. The North America Flow Cytometry Market is growing due to technological progress and high adoption in various research and diagnostic applications. Besides, the increasing incidence rates of diseases such as cancer and HIV to stimulate the adoption of flow cytometric technology in diagnostic applications.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Cell-based
5.1.3 Bead-based
5.1.4 Y-o-Y Growth Analysis, By Technology
5.1.5 Market Attractiveness Analysis, By Technology
5.1.6 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Reagents & Consumables
5.2.3 Flow Cytometry Instruments
5.2.3.1 Cell Analyzers
5.2.3.2 Cell Sorters
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3 Application
5.3.1 Introduction
5.3.2 Research Applications
5.3.2.1 Pharmaceutical & Biotechnology
5.3.2.2 Immunology
5.3.2.3 Apoptosis
5.3.2.4 Cell Cycle Analysis
5.3.2.5 Cell Sorting
5.3.2.6 Cell Viability
5.3.2.7 Other Research Applications
5.3.3 Clinical Applications
5.3.3.1 Cancer
5.3.3.2 Immunodeficiency Diseases
5.3.3.3 Hematology
5.3.3.4 Organ Transplantation
5.3.3.5 Other Clinical Applications
5.3.4 Industrial Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.3 End-users
5.3.1 Introduction
5.3.2 Commercial Organizations
5.3.3 Hospitals
5.3.4 Academic Institutions & Medical Schools
5.3.5 Clinical Testing Labs
5.3.6 Research Institutes
5.3.7 Y-o-Y Growth Analysis, By End-users
5.3.8 Market Attractiveness Analysis, By End-users
5.3.9 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By Application
6.1.3.5 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By Application
6.1.4.5 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By Application
6.1.5.5 By End-users
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton, Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Beckman Coulter, Inc.
8.3 Thermo Fisher Scientific, Inc.
8.4 Merck KGaA
8.5 Sysmex Partec GmbH
8.6 Luminex Corporation
8.7 Miltenyi Biotec GmbH
8.8 Bio-Rad Laboratories, Inc.
8.9 Sony Biotechnology
8.10 Life Technologies Corporation Inc.
8.11 EMD Millipore Corporation
8.12 Miltenyi Biotec
8.13 Thermo Fischer Scientific
8.14 Agilent Technologies, Inc.
8.15 Affymetix Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
